Angimet MR Tablet

About Angimet MR 35 mg Tablet

Angimet MR is a tablet from Orion Pharma Ltd. containing Trimetazidine Dihydrochloride 35 mg. It is used as add-on therapy in adults with stable angina pectoris when first-line antianginal treatments do not control symptoms or are not tolerated.

There are 13 brands of Trimetazidine Dihydrochloride listed in Bangladesh. 3 of them have a lower unit price than Angimet MR. The lowest listed price is Feelnor 20 mg Tablet at ৳ 3 per unit.

What is Angimet MR 35 mg Tablet?

Angimet MR is a 35 mg tablet made by Orion Pharma Ltd. Its active ingredient is Trimetazidine Dihydrochloride, which belongs to a group of other anti-anginal and anti-ischaemic drugs. It works by shifting the heart's energy production toward glucose, which uses oxygen more efficiently. Angimet MR is prescribed to adults as add-on therapy for the symptomatic treatment of stable angina pectoris when first-line antianginal medicines do not control symptoms well enough or are not tolerated. The doctor decides the dose and course.

Uses of Angimet MR

Angimet MR is used in adults as add-on therapy for the symptomatic treatment of stable angina pectoris. It is for people whose symptoms are not adequately controlled by first-line antianginal therapies or who cannot tolerate them. It is not a curative treatment for angina attacks, not an initial treatment for unstable angina, and not a treatment for myocardial infarction. Ask the doctor if you are unsure whether it is suitable for you.

How to use Angimet MR

Angimet MR is a tablet to be taken by mouth. The doctor decides the dose and how long you take it, and may assess the benefit after a period of treatment. Swallow the tablet as your doctor or pharmacist advises. Do not change the dose or stop the medicine on your own. If you miss a dose or have questions about how to take it, ask your doctor or pharmacist.

Side effects of Angimet MR

Like all medicines, Angimet MR can cause side effects. Common ones include dizziness, headache, abdominal pain, diarrhoea, indigestion, nausea, vomiting, rash, itching, hives and weakness. Tell your doctor or pharmacist if you notice any of these or other unusual symptoms. Do not stop the medicine without advice. Ask your doctor or pharmacist about anything you are worried about.

Safety and precautions

Angimet MR is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris, and it is not a treatment for myocardial infarction. It should be avoided in people with Parkinson's disease, parkinsonian symptoms, tremors, restless legs movement disorders, severe renal impairment, or allergy to the active substance or any excipient. Avoid it during pregnancy and breast-feeding. Ask your doctor first if you have any of these conditions or are pregnant or breast-feeding.

Frequently asked questions

What does the 35 mg strength and tablet form mean?

The 35 mg strength means each Angimet MR tablet contains 35 mg of Trimetazidine Dihydrochloride. The tablet form means it is taken by mouth. The doctor decides the dose and course; do not change it yourself.

What is Angimet MR used for and what kind of medicine is it?

Angimet MR is an anti-anginal and anti-ischaemic medicine. It is used in adults as add-on therapy for the symptomatic treatment of stable angina pectoris when first-line antianginal therapies do not control symptoms or are not tolerated. The doctor decides if it is suitable.

Who should avoid Angimet MR or ask the doctor first?

Avoid it if you have Parkinson's disease, parkinsonian symptoms, tremors, restless legs movement disorders, severe renal impairment, or allergy to its ingredients. It should not be used during pregnancy or breast-feeding. Ask your doctor first if any of these apply to you.

What is the price of Angimet MR?

The listed price is ৳ 6.00. Ask your pharmacist about availability and any other costs.

Indications

Trimetazidine Dihydrochloride is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies.

Pharmacology

Trimetazidine Dihydrochloride is the first 3- keto acyl CoA thiolase inhibitor (KAT), a metabolic anti-ischemic agent with proven benefits for all coronary patients. Trimetazidine Dihydrochloride inhibits fatty acid pathway by inhibiting 3-keto acyl CoA thiolase enzyme and transfers oxygen to glucose pathway. Since glucose pathway is more efficient in producing energy, the same oxygen produces more energy and makes the heart more active. Moreover, the aerobic oxidation of glucose stops production of lactic acid, which prevents angina pectoris.

Dosage & Administration

The recommended dose of Trimetazidine is 35 mg twice daily or 20 mg tablet thrice daily during meals. The benefit of the treatment should be assessed after three months and Trimetazidine should be discontinued if there is no treatment response.

Interaction

No drug interaction so far has been reported. In particular, no interaction has been reported with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidemic agents or digitalis preparation.

Contraindications

Trimetazidine is contraindicated in patients who have hypersensitivity to the active substance or to any of the excipients. It is also is contraindicated in patients with Parkinson’s disease, parkinsonian symptoms, tremors, restless legs movement disorders, severe renal impairment.

Side Effects

Trimetazidine is safe and well tolerated. The Common side effects associated with Trimetazidine are dizziness, headache, abdominal pain, diarrhoea, dyspepsia, nausea, vomiting, rash, pruritus, urticaria and asthenia

Pregnancy & Lactation

There is no data on the use of Trimetazidine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure, it is preferable to avoid the use of Trimetazidine during pregnancy. It is unknown whether Trimetazidine is excreted in human milk. A risk to the newborns/infants cannot be excluded. Trimetazidine should not be used during breast-feeding.

Precautions & Warnings

Trimetazidine is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris. It is also not a treatment for myocardial infarction.

Storage Conditions

Keep in a dry place away from light and heat. Keep out of the reach of children.

Alternative brands of Trimetazidine Dihydrochloride

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.